Fundamentals screen · refreshed after the Sep 28, 2026 close
Net-cash companies: Healthcare
Companies whose cash and investments exceed all debt by at least a quarter of their market value. Net cash is cash plus short-term investments minus debt, from the latest quarterly balance sheet.
| # | Company | Price | Net cash | Mkt cap | Revenue YoY | P/E |
|---|---|---|---|---|---|---|
| 1 | EIKNEikon TherapeuticsHealthcare | $7.91 | $531.2M | $428.4M | — | — |
| 2 | ARVNArvinasHealthcare | $7.51 | $567.6M | $491.1M | +1014.7% | 52.8× |
| 3 | ARTVArtiva BiotherapeuticsHealthcare | $7.05 | $349.4M | $344.7M | — | — |
| 4 | BIOABioAge LabsHealthcare | $7.18 | $318.7M | $329.5M | +1.6% | — |
| 5 | JANXJanux TherapeuticsHealthcare | $16.58 | $970.9M | $1.01B | — | — |
| 6 | BBOTBridgeBio Oncology TherapeuticsHealthcare | $3.81 | $225.7M | $305.5M | — | — |
| 7 | WVEWave Life SciencesHealthcare | $3.67 | $490.6M | $723.2M | −73.9% | — |
| 8 | ASMBAssembly BiosciencesHealthcare | $23.61 | $320.4M | $480.7M | +38.9% | — |
| 9 | CCCCC4 TherapeuticsHealthcare | $3.12 | $253.7M | $383.2M | +2.8% | — |
| 10 | EVMNEvommuneHealthcare | $8.39 | $200.4M | $304.5M | — | — |
| 11 | PRTAProthenaHealthcare | $8.72 | $288.2M | $447.7M | −77.1% | — |
| 12 | KLRAKailera TherapeuticsHealthcare | $11.12 | $916.7M | $1.44B | — | — |
| 13 | CRONCronos Group Inc. Common ShareHealthcare | $3.41 | $797.0M | $1.26B | +59.5% | 18.0× |
| 14 | GLUEMonte Rosa TherapeuticsHealthcare | $11.71 | $621.1M | $999.0M | −61.3% | — |
| 15 | OLMAOlema PharmaceuticalsHealthcare | $8.61 | $458.1M | $753.4M | — | — |
| 16 | CABACabaletta BioHealthcare | $2.00 | $205.1M | $339.1M | — | — |
| 17 | ALLOAllogene TherapeuticsHealthcare | $1.63 | $332.6M | $563.2M | — | — |
| 18 | CTMXCytomX TherapeuticsHealthcare | $2.69 | $330.3M | $586.1M | −92.4% | — |
| 19 | ALMSAlumisHealthcare | $7.16 | $502.3M | $926.8M | −37.7% | — |
| 20 | PROKProKidneyHealthcare | $1.61 | $181.6M | $336.4M | −32.1% | — |
| 21 | KURAKura OncologyHealthcare | $10.61 | $509.2M | $943.9M | +36.5% | — |
| 22 | RLMDRelmada TherapeuticsHealthcare | $3.79 | $217.7M | $404.3M | — | — |
| 23 | VNDAVanda PharmaceuticalsHealthcare | $5.17 | $166.9M | $312.6M | −3.9% | — |
| 24 | AVIRAtea PharmaceuticalsHealthcare | $5.20 | $219.5M | $417.1M | — | — |
| 25 | MPLTMapLight TherapeuticsHealthcare | $10.45 | $304.7M | $580.8M | — | — |
| 26 | ZURAZura Bio LimitedHealthcare | $4.10 | $205.1M | $392.9M | — | — |
| 27 | ENTAEnanta PharmaceuticalsHealthcare | $12.62 | $189.5M | $367.4M | −21.6% | — |
| 28 | BNTCBenitec BiopharmaHealthcare | $10.02 | $180.0M | $349.5M | — | — |
| 29 | AURAAura BiosciencesHealthcare | $6.15 | $323.8M | $637.8M | — | — |
| 30 | ALTAltimmuneHealthcare | $2.96 | $291.5M | $575.8M | −100.0% | — |
| 31 | JBIOJade BiosciencesHealthcare | $14.35 | $461.2M | $912.6M | — | — |
| 32 | AVTXAvalo TherapeuticsHealthcare | $15.08 | $400.3M | $808.7M | — | — |
| 33 | CTNMContineum TherapeuticsHealthcare | $12.73 | $236.6M | $478.9M | — | — |
| 34 | TECXTectonic TherapeuticHealthcare | $23.51 | $226.9M | $459.6M | — | — |
| 35 | PRLDPrelude Therapeutics IncorporatedHealthcare | $3.91 | $151.8M | $312.0M | — | — |
| 36 | SLDBSolid BiosciencesHealthcare | $7.28 | $377.7M | $780.6M | — | — |
| 37 | AKTSAktis OncologyHealthcare | $19.35 | $517.3M | $1.08B | — | — |
| 38 | LRMRLarimar TherapeuticsHealthcare | $3.17 | $156.3M | $329.3M | — | — |
| 39 | CAPRCapricor TherapeuticsHealthcare | $8.71 | $237.9M | $506.4M | — | — |
| 40 | ARCTArcturus Therapeutics HoldingsHealthcare | $14.46 | $191.5M | $411.0M | −89.5% | — |
| 41 | MLTXMoonLake ImmunotherapeuticsHealthcare | $11.56 | $437.5M | $983.8M | — | — |
| 42 | ABEOAbeona TherapeuticsHealthcare | $5.29 | $131.8M | $302.5M | +2745.0% | — |
| 43 | KARDKardiganHealthcare | $14.78 | $597.6M | $1.38B | — | — |
| 44 | VORVor BiopharmaHealthcare | $18.31 | $466.1M | $1.08B | — | 1.7× |
| 45 | DNAGinkgo Bioworks HoldingsHealthcare | $10.46 | $302.2M | $704.4M | −48.5% | — |
| 46 | FDMT4D Molecular TherapeuticsHealthcare | $14.56 | $341.7M | $804.4M | +25106.7% | — |
| 47 | DMRADamora TherapeuticsHealthcare | $20.75 | $540.5M | $1.28B | — | — |
| 48 | BEAMBeam TherapeuticsHealthcare | $24.23 | $1.05B | $2.50B | −94.2% | — |
| 49 | CRMDCorMedixHealthcare | $7.89 | $256.7M | $615.0M | +156.5% | 3.3× |
| 50 | FLGTFulgent GeneticsHealthcare | $22.36 | $256.6M | $615.2M | +4.4% | — |
Method & sources
Computed after each close from Massive / Polygon prices (split-adjusted), SEC filings, FINRA short-interest settlements and FMP earnings dates. Rows are rebuilt every session; a stock appears only when every criterion is met with current data. Full methodology
Informational screen, not a recommendation.